Healthcare Triangle, Inc.
Healthcare Triangle provides information technology platforms and services to hospitals, clinics, healthcare providers, insurers, pharmaceutical and life sciences companies, biotech firms, and medical device manufacturers. Its offerings include cloud transformation, data management and analytics, security and compliance, EHR implementation and support, interoperability services, and managed cloud services. Proprietary platforms CloudEz and DataEz support cloud infrastructure and data analytics; Readabl.AI extracts health information from documents, Ziloy.AI provides digital mental wellness programs, and Ezovion is a cloud-based hospital information management system. Healthcare Triangle earns most of its revenue from employees providing software services, including advisory, implementation, and development, and managed services and support, including post-implementation support and cloud hosting. Readabl.AI and Ezovion are also offered as subscription SaaS products. The company’s principal executive office is in Pleasanton, California.
No SEC Form 4 filings for $HCTI in the last 30 days.
See all $HCTI insider activity →Healthcare Triangle (HCTI) reported Q3 2026 results with nine-month revenue up 162% to $28.2M and gross margin up 354%. Q3 revenue grew 161% to $9.12M, with gross margin at 22.8%. The AI-powered Customer Engagement Services segment contributed 72% of Q3 revenue, driving margin expansion. Management expects continued margin improvement.
Healthcare Triangle (HCTI) is expanding into Indonesia, targeting a $20–45 million opportunity over 24–36 months. The country's healthcare market was valued at $11.6 billion in 2024, according to Nexdigm. The company is discussing pilots and partnerships for its Ezovion, Ziloy.ai, and neurotechnology platforms.
Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan PLEASANTON, Calif., Oct. 21, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI ) (“HCTI” or the “Company”), a leader in digital transformation solutions incl
Over the past 7 days, AlphAI's AI scored 5 news stories mentioning HCTI (Healthcare Triangle, Inc.). Coverage has skewed bearish: 1 bullish, 2 neutral, and 2 bearish.
Recent HCTI coverage spans corporate actions, financial news and earnings.
Strong top‑line growth but still loss; market may price modest upside on margin improvement.
The disclosed pipeline may lift the stock modestly if investors view the Indonesia expansion as credible.
The reverse split will reduce shares outstanding and raise the per‑share price, likely providing short‑term price support but may limit liquidity.
The approved reverse split and potential 20% issuance could dilute existing shares and alter price perception.
Purpose Health secured several multi-year contracts, expanding HCTI's service footprint in healthcare IT.
AlphAI scores every news story that mentions HCTI with an AI model for sentiment and relevance, and aggregates insider trades from Healthcare Triangle, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Healthcare Triangle (HCTI) reported Q3 2026 results with nine-month revenue up 162% to $28.2M and gross margin up 354%. Q3 revenue grew 161% to $9.12M, with gross margin at 22.8%. The AI-powered Customer Engagement Services segment contributed 72% of Q3 revenue, driving margin expansion. Management expects continued margin improvement.
Healthcare Triangle (HCTI) is expanding into Indonesia, targeting a $20–45 million opportunity over 24–36 months. The country's healthcare market was valued at $11.6 billion in 2024, according to Nexdigm. The company is discussing pilots and partnerships for its Ezovion, Ziloy.ai, and neurotechnology platforms.
Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan PLEASANTON, Calif., Oct. 21, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI ) (“HCTI” or the “Company”), a leader in digital transformation solutions incl
Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On October 23, 2026, at the virtual special meeting of stockholders (the “Special Meeting”), the stockholders of Healthcare Triangle, Inc. (the “Company”): (i) approved one or more amendments to our Amended and Resta
Healthcare Triangle's subsidiary, Purpose Health, secured multiple multi-year contracts in healthcare tech, including EHR optimization, cybersecurity, and IT services for a global tech center. The wins follow its July 2026 launch and include work with a university health system and rural hospitals in three states. CEO Sumit Ganguli highlighted the company's momentum and commitment to AI-led solutions.
Healthcare Triangle, Inc. (HCTI) announced a 1-for-20 reverse stock split to comply with Nasdaq's $1 minimum bid price requirement. The split, effective October 26, 2026, will reduce shares outstanding from 17.7M to 886.5K. The company aims to increase its stock price and regain compliance with Nasdaq's listing rules.
Healthcare Triangle (HCTI) reports six signed AI engagements in its Teyame business, estimated to generate about $4.65M in annual revenue. The deals involve insurance and financial services clients, with starts scheduled for late 2026. An additional unsigned engagement could add $3.31M annually. The company's CFO highlights the combination of AI and sales expertise to enhance customer reach.
Nasdaq notified Healthcare Triangle (HCTI) of a delisting due to noncompliance with the $1.00 minimum bid price rule and prior reverse splits. The company plans to appeal, which would stay the suspension and allow continued trading under HCTI.
Healthcare Triangle (HCTI) signed an MOU with AI World to form a joint venture for AI-enabled humanoid nursing robots in North America. HCTI will hold 70% ownership, leveraging its hospital network. The robots aim to assist with patient hygiene, addressing nursing shortages. The global market for robotic nurse assistants is projected to reach $4.4B by 2033. The venture is subject to due diligence and regulatory approvals.
Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 22, 2026, Healthcare Triangle, Inc. (“HCTI” or the “Company”), a Delaware corporation, entered into the First Amendment to the Equity Purchase Agreement (the “Amendment”), which amends the Equity Purchase Agreemen
